Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and molecular characterization of non-PIK3CA-related vascular malformations with overgrowth in a pediatric cohort. | World J Pediatr | 2026 | 42814223 | PubTator, text mining | PubMed |
| Case report: A Newly Identified G-protein Subunit α-11 Loss-of-Function Variant Causing Familial Hypocalciuric Hypercalcemia Type 2 in an Italian Kindred. | Front Endocrinol (Lausanne) | 2026 | 42787214 | PubTator, text mining | PubMed |
| Peripheral vasomotor symptoms: Expanding the phenotype of GNA11-related capillary malformations. | J Eur Acad Dermatol Venereol | 2026 | 42755085 | PubTator, text mining | PubMed |
| Circumscribed Meningeal Melanocytic Neoplasms: CNS WHO Grade, Molecular Profile, and Clinical Outcomes. | Brain Pathol | 2026 | 42740583 | PubTator, text mining | PubMed |
| Significantly elevated calcium levels and gallstone disease in a patient with familial hypocalciuric hypercalcaemia. | Endocrinol Diabetes Metab Case Rep | 2026 | 42709961 | PubTator, text mining | PubMed |
| Abnormal Enamel Mineralization and Hypercalcemia due to GNA11 Variants. | J Dent Res | 2026 | 42670332 | PubTator, text mining | PubMed |
| SUMOylation-Driven Subtype Heterogeneity and Prognostic Biomarkers in Renal Cell Carcinoma. | Curr Issues Mol Biol | 2026 | 42651750 | PubTator, text mining | PubMed |
| Does the ERBB/EGF Signaling Network Serve as a Nexus for Oncogenic Signals in Uveal Melanoma? | Biomolecules | 2026 | 42650747 | PubTator, text mining | PubMed |
| Primary diffuse leptomeningeal melanomatosis presenting as chronic meningitis and dense spinal plaques. | Pract Neurol | 2026 | 42613178 | PubTator, text mining | PubMed |
| SMARCB1 (INI1)-deficient malignant melanocytic neoplasm with histologically confirmed vertebral metastases in a young adult: a case report. | Front Oncol | 2026 | 42528567 | PubTator, text mining | PubMed |
| GJA4-Associated Cavernous Venous Malformation: A Distinct Morphologic and Molecular Subtype of Venous Malformation. | Mod Pathol | 2026 | 42520969 | PubTator, text mining | PubMed |
| A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma. | Cancers (Basel) | 2026 | 42512298 | PubTator, text mining | PubMed |
| Combination of Three Herbal Components (ISL, Que, Meth) Suppresses Uveal Melanoma Growth via Gαq/MEK/YAP Axis Modulation and Apoptosis. | Biomedicines | 2026 | 42512070 | PubTator, text mining | PubMed |
| Uveal melanoma as a stress-dependent malignancy governed by a reprogrammable stress-adaptation network. | Transl Oncol | 2026 | 42508144 | PubTator, text mining | PubMed |
| A modern review of uveal melanoma: molecular insights, clinical management, and emerging therapies. | Melanoma Res | 2026 | 42456092 | PubTator, text mining | PubMed |
| Gene therapy for uveal melanoma. | Clin Transl Oncol | 2026 | 42446821 | PubTator, text mining | PubMed |
| An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial. | Nat Med | 2026 | 42443515 | PubTator, text mining | PubMed |
| Genomic Landscape of GNAQ and GNA11 Mutations in Metastatic Solid Tumors: A Real-World Data Analysis. | JCO Precis Oncol | 2026 | 42407004 | PubTator, text mining | PubMed |
| Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy. | PLoS One | 2026 | 42406708 | PubTator, text mining | PubMed |
| The rs10781468 Genetic Polymorphism of the Gαq (GNAQ) Gene Is Associated With Responsiveness to Opioid Analgesics in Patients With Postoperative and Cancer Pain: An Exploratory Study. | Neuropsychopharmacol Rep | 2026 | 42376735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers